StockData
Parabilis Medicines, Inc. logo

Parabilis Medicines, Inc. (PBLS) stock

PBLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$28.25−0.20 (-0.70%)

Close on Nov 17, 2026Market cap $3.49BP/E –Yield –

Parabilis Medicines pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Parabilis Medicines

Parabilis Medicines has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Parabilis Medicines figures

See a number that looks wrong?